Research Progress and Mechanism of cGAS-STING Pathway in Tumor Immunotherapy

被引:0
|
作者
Wang, Shihao [1 ]
Shi, Wanrui [1 ]
Liu, Yi [1 ]
Zhang, Hao [1 ]
机构
[1] Jilin Univ, Coll Chem, Changchun 130012, Peoples R China
来源
CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE | 2025年 / 46卷 / 01期
关键词
Cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes signaling pathway; Tumor; Immunotherapy; Nanomedicine; CANCER; DNA; NANOPARTICLES; INFLAMMATION; STRATEGIES; ADJUVANTS; COMPLEX; ADAPTER;
D O I
10.7503/cjcu20240241
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The cyclic guanosine monophosphate-adenosine monophosphate(GMP-AMP) synthase(cGAS protein)- stimulator of interferon genes(STING protein)(cGAS-STING) signaling pathway is a crucial pathway for recognizing abnormal DNA in the cytoplasm and activating the innate immune response system. After recognizing abnormal DNA in the cytoplasm, cGAS protein can catalyze the synthesis of cyclic guanosine diphosphate adenosine(cyclic GMP-AMP, cGAMP) from adenosine triphosphate(ATP) and guanosine triphosphate(GTP). cGAMP, as a second messenger, activates the stimulator of interferon gene(STING protein), promoting the release of type I interferons and thus initiating a series of immune responses. The cGAS-STING pathway can regulate tumor metastasis and growth, participate in anti-tumor innate immune responses, and exploring the mechanism of action of the cGAS-STING pathway is of great significance in tumor immunotherapy. This review introduces the mechanism of action of the cGAS-STING pathway and summarizes various strategies currently used to activate the cGAS-STING pathway in anti-tumor immunotherapy.
引用
收藏
页数:10
相关论文
共 55 条
  • [21] Nuclear cGAS suppresses DNA repair and promotes tumorigenesis
    Liu, Haipeng
    Zhang, Haiping
    Wu, Xiangyang
    Ma, Dapeng
    Wu, Juehui
    Wang, Lin
    Jiang, Yan
    Fei, Yiyan
    Zhu, Chenggang
    Tan, Rong
    Jungblut, Peter
    Pei, Gang
    Dorhoi, Anca
    Yan, Qiaoling
    Zhang, Fan
    Zheng, Ruijuan
    Liu, Siyu
    Liang, Haijiao
    Liu, Zhonghua
    Yang, Hua
    Chen, Jianxia
    Wang, Peng
    Tang, Tianqi
    Peng, Wenxia
    Hu, Zhangsen
    Xu, Zhu
    Huang, Xiaochen
    Wang, Jie
    Li, Haohao
    Zhou, Yilong
    Liu, Feng
    Yan, Dapeng
    Kaufmann, Stefan H. E.
    Chen, Chang
    Mao, Zhiyong
    Ge, Baoxue
    [J]. NATURE, 2018, 563 (7729) : 131 - +
  • [22] CD-NTase family member MB21D2 promotes cGAS-mediated antiviral and antitumor immunity
    Liu, Hansen
    Yan, Zhenzhen
    Zhu, Deyu
    Xu, Haiyan
    Liu, Feng
    Chen, Tian
    Zhang, Honghai
    Zheng, Yi
    Liu, Bingyu
    Zhang, Lei
    Zhao, Wei
    Gao, Chengjiang
    [J]. CELL DEATH AND DIFFERENTIATION, 2023, 30 (04): : 992 - 1004
  • [23] Advances in Cancer Vaccine Research
    Liu, Nian
    Xiao, Xiangyu
    Zhang, Ziqiang
    Mao, Chun
    Wan, Mimi
    Shen, Jian
    [J]. ACS BIOMATERIALS SCIENCE & ENGINEERING, 2023, 9 (11) : 5999 - 6023
  • [24] Activation of STING by targeting a pocket in the transmembrane domain
    Lu, Defen
    Shang, Guijun
    Li, Jie
    Lu, Yong
    Bai, Xiao-chen
    Zhang, Xuewu
    [J]. NATURE, 2022, 604 (7906) : 557 - +
  • [25] Nanoplatform-based strategies for enhancing the lethality of current antitumor PDT
    Lu, Xin-Xin
    Xue, Chun
    Dong, Jian-Hui
    Zhang, Yi-Zhou
    Gao, Fan
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2024, 12 (13) : 3209 - 3225
  • [26] cGAS is activated by DNA in a length-dependent manner
    Luecke, Stefanie
    Holleufer, Andreas
    Christensen, Maria H.
    Jonsson, Kasper L.
    Boni, Gerardo A.
    Sorensen, Lambert K.
    Johannsen, Mogens
    Jakobsen, Martin R.
    Hartmann, Rune
    Paludan, Soren R.
    [J]. EMBO REPORTS, 2017, 18 (10) : 1707 - 1715
  • [27] Application of MOF materials as drug delivery systems for cancer therapy and dermal treatment
    Mallakpour, Shadpour
    Nikkhoo, Elham
    Hussain, Chaudhery Mustansar
    [J]. COORDINATION CHEMISTRY REVIEWS, 2022, 451
  • [28] Research progress on tumor whole-cell vaccines prepared with nanoparticles for tumor immunotherapy
    Mao, Weihong
    Jia, Sheng
    Chen, Ping
    [J]. JOURNAL OF NANOPARTICLE RESEARCH, 2023, 25 (07)
  • [29] Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
    Motedayen Aval, Leila
    Pease, James E.
    Sharma, Rohini
    Pinato, David J.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 31
  • [30] IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
    Munn, David H.
    Mellor, Andrew L.
    [J]. TRENDS IN IMMUNOLOGY, 2016, 37 (03) : 193 - 207